Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

3articles mentioning drugs

10drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: serplulimab ×

serplulimab

This drug is selected. Its supporting articles are shown below.

Serplulimab3

Articles mentioning serplulimab

3 articles · page 1 of 1

1349 Serplulimab combined with bevacizumab and chemotherapy as first-line treatment for recurrent or metastatic cervical cancer (ASTRUM-CC01): a phase II trial

jitc · abstract · 2025-11-07 · 6 matching annotations

97.1%

bevacizumab serplulimab HLX04 cisplatin paclitaxel Cervical cancer

…sions First-line treatment with serplulimab in combination with bevacizumab and chemotherapy demonstrated promising antitumor activity and …

Simplified perioperative serplulimab and chemotherapy for resectable squamous NSCLC: a phase II trial with biomarker analysis

jitc · abstract · 2026-05-11 · 3 matching annotations

97.4%

carboplatin serplulimab paclitaxel taxane-carboplatin nab-paclitaxel taxane NCT05775796 sq-NSCLC Squamous non-small cell lung cancer NSCLC

…ng serplulimab with a taxane (paclitaxel or nab-paclitaxel) and carboplatin in patients with resectable stage II-IIIA sq-NSCLC.Methods This…

Mechanistic insights into PD-1 inhibitor-associated immune thrombocytopenia: a case report integrating longitudinal transcriptomic profiling

jitc · abstract · 2025-12-31 · 1 matching annotations

96.7%

trastuzumab serplulimab stage IV gastric adenocarcinoma chemotherapy advanced malignancies immune thrombocytopenia (ITP)

…owing programmed death receptor-1 (PD-1) inhibitor serplulimab, trastuzumab and chemotherapy. Notably, longitudinal peripheral blood mononu…